What is AEMD's current stock price?

AEMD (Aethlon Medical, Inc.) is currently trading at $2.20 with a market cap of $1.7M.

What sector is Aethlon Medical, Inc. in?

Aethlon Medical, Inc. (AEMD) operates in the Healthcare sector, specifically in the Medical - Devices industry.

InvestLog

AEMD Aethlon Medical, Inc.

Healthcare

$2.20+4.76%ClosedMarket Cap: $1.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.27

P/S

0.00

EV/EBITDA

0.44

DCF Value

$27.87

FCF Yield

-102706.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-219.4%

ROA

-143.0%

ROIC

-103.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 null	$0.00	$-2.0M	$—
Q2 null	$0.00	$-1.5M	$—
Q1 null	$0.00	$-1.8M	$—
Q4 null	$0.00	$-6.3M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy2 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Neutral

2025-08-14

Trading Activity

Insider Trades

View All

Shah Chetandirector

SellTue Apr 21

Rossetti Angeladirector

SellTue Apr 21

Gikakis Nicolasdirector

SellTue Apr 21

BROENNIMAN EDWARD Gdirector

SellTue Apr 21

Shah Chetandirector

SellWed Apr 01

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

1.50

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Peers